On the one hand, TiBcs have the function of promoting tumors by producing IL-10, TGF-β, and IL-35; by the lymphotoxin/ IKKa-BMI1 signaling pathway; or by directly promoting tumor progression through engaging PD-L1/PD-1 molecules [18, 19]. This evidence concerns the gene IL10 and neoplasm.